DK0444302T3 - Immunoassayfremgangsmåde omfattende deaktivering af endogen, alkalisk phosphatase - Google Patents

Immunoassayfremgangsmåde omfattende deaktivering af endogen, alkalisk phosphatase

Info

Publication number
DK0444302T3
DK0444302T3 DK90125246.0T DK90125246T DK0444302T3 DK 0444302 T3 DK0444302 T3 DK 0444302T3 DK 90125246 T DK90125246 T DK 90125246T DK 0444302 T3 DK0444302 T3 DK 0444302T3
Authority
DK
Denmark
Prior art keywords
alkaline phosphatase
immunoassay method
endogenous alkaline
deactivating endogenous
deactivating
Prior art date
Application number
DK90125246.0T
Other languages
Danish (da)
English (en)
Inventor
Colleen M Nycz
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of DK0444302T3 publication Critical patent/DK0444302T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
DK90125246.0T 1990-03-01 1990-12-21 Immunoassayfremgangsmåde omfattende deaktivering af endogen, alkalisk phosphatase DK0444302T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/486,650 US5279935A (en) 1990-03-01 1990-03-01 Method of immunossay including deactivation of endogenous alkaline phosphatase

Publications (1)

Publication Number Publication Date
DK0444302T3 true DK0444302T3 (da) 1996-09-02

Family

ID=23932730

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90125246.0T DK0444302T3 (da) 1990-03-01 1990-12-21 Immunoassayfremgangsmåde omfattende deaktivering af endogen, alkalisk phosphatase

Country Status (12)

Country Link
US (1) US5279935A (fi)
EP (1) EP0444302B1 (fi)
JP (1) JPH06105254B2 (fi)
AT (1) ATE138201T1 (fi)
AU (1) AU625790B2 (fi)
CA (1) CA2030649A1 (fi)
DE (1) DE69027020T2 (fi)
DK (1) DK0444302T3 (fi)
ES (1) ES2087118T3 (fi)
FI (1) FI911013A (fi)
GR (1) GR3020247T3 (fi)
IE (1) IE904127A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2023850A1 (en) * 1989-09-28 1991-03-29 Randal A. Hoke Stabilizing reagent for membrane immunoassay
DE69127383T2 (de) * 1990-01-19 1998-03-05 Mina Ltd Gerät und Verfahren zur Untersuchung von Blut und zur Fingerabdruck-Identifikation
AU6247494A (en) * 1993-02-17 1994-09-14 Dade International Inc. Method and composition for reducing the effects of endogenous alkaline phosphatase
US5516647A (en) * 1993-11-05 1996-05-14 Abbott Laboratories Compounds useful as alkaline phosphatase inhibitors and therapeutic agents
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US5874216A (en) 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
WO2001055217A1 (en) * 2000-01-27 2001-08-02 Medimmune, Inc. Ultra high affinity neutralizing antibodies
EP2341075A1 (en) * 2000-03-01 2011-07-06 MedImmune, LLC Antibodies binding to the f protein of a respiratory syncytial virus (rsv)
CA2410823A1 (en) * 2000-05-31 2001-12-06 Jolanta Vidugiriene Assay for kinases and phosphatases
AU2001276703A1 (en) * 2000-08-01 2002-02-13 International Reagents Corporation Method of pretreating sample
US7052831B2 (en) * 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
JP3973876B2 (ja) * 2001-10-30 2007-09-12 株式会社三菱化学ヤトロン 新規の細菌分析方法
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1978363B1 (en) * 2007-04-03 2010-02-24 Sysmex Corporation Immunoassay method, reagent kit for detecting alkaline phosphatase, and reagent kit for immunoassay
JP4830966B2 (ja) * 2007-05-11 2011-12-07 富士レビオ株式会社 不活化アルカリフォスファターゼの製造方法及び酵素免疫測定用の精度向上剤
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US8476008B2 (en) * 2008-07-23 2013-07-02 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
WO2010132447A2 (en) 2009-05-11 2010-11-18 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
EP2550529B1 (en) 2010-03-23 2021-11-17 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
JP5716501B2 (ja) * 2011-04-04 2015-05-13 東洋紡株式会社 検体の前処理方法
EP2771349B1 (en) 2011-09-16 2020-02-26 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
EP3418397B1 (en) 2012-01-24 2020-10-07 CD Diagnostics, Inc. System for detecting infection in synovial fluid
WO2013119763A1 (en) 2012-02-07 2013-08-15 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
US8945827B2 (en) 2013-03-13 2015-02-03 Awareness Technology, Inc. Serological methods and diagnostic tests for syphilis antibodies
EP3286216B1 (en) 2015-04-23 2022-06-08 Nevada Research & Innovation Corporation Fungal detection using mannan epitope
WO2017023929A1 (en) 2015-08-04 2017-02-09 Cd Diagnostics, Inc. Methods for detecting adverse local tissue reaction (altr) necrosis
EP3387154A4 (en) 2015-12-09 2019-05-15 Intuitive Biosciences, Inc. AUTOMATED SILVER ENHANCEMENT SYSTEM
US20200200735A9 (en) 2016-02-22 2020-06-25 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
JP6659406B2 (ja) * 2016-03-04 2020-03-04 田中貴金属工業株式会社 イムノクロマトグラフィー装置
ES2866880T3 (es) 2016-04-13 2021-10-20 Inst Nat Sante Rech Med Métodos y kits para la detección rápida del clon O25B-ST131 de Escherichia Coli
US11300576B2 (en) 2019-01-29 2022-04-12 Arizona Board Of Regents On Behalf Of Arizona State University DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1006557B (it) * 1971-09-08 1976-10-20 Bagshawe Kenneth Dawson Cella di reazione particolarmente utile in prove di radioimmunita
US4277560A (en) * 1978-10-24 1981-07-07 Technicon Instruments Corporation Enzyme immunoassays using immobilized reagents in a flowing stream
US4246339A (en) * 1978-11-01 1981-01-20 Millipore Corporation Test device
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
US4782016A (en) * 1985-01-18 1988-11-01 Eastman Kodak Company Analytical element and method for determination of theophylline by enzyme inhibition
US4656128A (en) * 1985-01-22 1987-04-07 Research Corporation Modified alkaline phosphatase
US4738932A (en) * 1985-12-03 1988-04-19 Advanced Polymer Systems, Inc. Reaginic test for syphilis
JPS62170850A (ja) * 1986-01-23 1987-07-27 Wako Pure Chem Ind Ltd 免疫化学的測定法
US4812293A (en) * 1986-06-30 1989-03-14 Becton, Dickinson And Company Vacuum actuated assay device and method of using same
CA1289876C (en) * 1986-07-15 1991-10-01 Richard R. Anderson Solid phase system incorporating tetrazolium salts for use in ligand-receptor assays
US4956302A (en) * 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
IL85018A0 (en) * 1988-01-03 1988-06-30 Orgenics Ltd Stable chromogenic substrate mixture of indoxyl phosphate and tetrazolium salt,method of making and using same in biological and diagnostic assays

Also Published As

Publication number Publication date
ATE138201T1 (de) 1996-06-15
DE69027020T2 (de) 1996-10-31
EP0444302B1 (en) 1996-05-15
JPH06105254B2 (ja) 1994-12-21
JPH04249768A (ja) 1992-09-04
FI911013A (fi) 1991-09-02
CA2030649A1 (en) 1991-09-02
DE69027020D1 (de) 1996-06-20
AU625790B2 (en) 1992-07-16
US5279935A (en) 1994-01-18
EP0444302A1 (en) 1991-09-04
FI911013A0 (fi) 1991-02-28
IE904127A1 (en) 1991-09-11
GR3020247T3 (en) 1996-09-30
AU6701790A (en) 1991-09-05
ES2087118T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
DK0444302T3 (da) Immunoassayfremgangsmåde omfattende deaktivering af endogen, alkalisk phosphatase
TR24372A (tr) Org.peroksi asit agartma oen-maddelerine dayanan aktivatoer bilesimleri
FI875398A (fi) Reagens foer cellseparering.
DE3854876D1 (de) Biochemisches Analysegerät.
DE69019621T2 (de) Ein automatisches System zum Anpassen der Ausgangsimpedanz von schnellen CMOS-Treibern.
DE69023951T2 (de) Verfahren zur Herstellung von Kontakten an einer Halbleitervorrichtung.
ES2037723T3 (es) Amidinacion selectiva de diaminas.
DE3774208D1 (de) Elektrochemischer test von haemoglobin.
DE58907866D1 (de) Photopolymerisierbare, zur Herstellung von Druckformen geeignete Druckplatte.
DE3789121D1 (de) Entwicklungsverfahren.
FI954029A0 (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
DE3854209D1 (de) Analyse von organischen Substanzen.
DK603087D0 (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
DE3683332D1 (de) Cyanatabspaltung von pergolidzwischenverbindung.
DE3750756D1 (de) Ausführung von Fehlererkennung unter Verwendung eines ungebrauchten Modulo-m-Kodes.
DE3784792T2 (de) Biochemisches verfahren.
NO168864C (no) Fremgangsmaate for dekaffeinering av raakaffe.
ES2015952B3 (es) Membranas compuestas.
DE69012172D1 (de) Herstellung einer organischen Membrane.
DE3875878D1 (de) Mit hoher schnelligkeit betreibbares und zur implementierung als integrierter schaltkreis geeigneter flipflop.
DE3872888D1 (de) Immunassay unter benutzung der mikropartikelneutralisierung.
DE3773342D1 (de) Katalysierte alkylierung von halogenpyridinaten ohne zusatz von organischen loesungsmitteln.
DE3766567D1 (de) Verfahren zur herstellung von alkalimetallbenzolsulfinaten.
DE3862840D1 (de) Verfahren zur herstellung von alkylierten dodecahydro-naphtho(2,1-b)-furanen.
FI870500A0 (fi) Reagens foer bestaemning av antikropp mot virusantigen.